Skip to content
Recall Observatory FDA recall evidence

Drug product

Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30

D-841-2013

March 07, 2013

Class II

Product summary

Firm
Sanofi US
Event
Event 65701
Status
Terminated
Classification
Class II
Quantity
2,462 bottles
Official record key
drug-enforcement:D-841-2013

Official wording

Reason: Subpotent drug: low fill volume in some of the capsules

Code information: Lot # 3097657, Exp 3/15

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent